IHS Chemical Week

Regions :: Eastern Europe :: Russia

Russia’s largest pharmaceutical company to buy Singapore-based API supplier for $590 million

12:36 AM MDT | August 19, 2013 | Deepti Ramesh

Pharmstandard (Moscow), Russia’s leading pharmaceutical company, says it will acquire Bever Pharmaceutical (Singapore), a supplier of active pharmaceutical ingredients (APIs), for a total of $590 million. Russian businessman Alexander Shuster, a non-executive board member of Pharmstandard, currently owns 100% stake in Bever. Following the completion of the transaction, Shuster will become the second largest shareholder of Pharmstandard with a stake of about 18.74%. The strategic rationale for the proposed acquisition includes securing a long-term supply of...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa